<document xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:z="http://www.ebi.ac.uk/z" source="Whatizit"><text><SENT sid="0" pm="."><plain>A 25-year-old female patient developed <z:hpo ids='HP_0002315'>headache</z:hpo> and <z:hpo ids='HP_0001085'>papilledema</z:hpo> under sulphasalazine treatment for <z:hpo ids='HP_0100279'>ulcerative colitis</z:hpo> </plain></SENT>
<SENT sid="1" pm="."><plain>The patient met the International <z:hpo ids='HP_0002315'>Headache</z:hpo> Society's criteria for idiopathic intracranial <z:hpo ids='HP_0000822'>hypertension</z:hpo> </plain></SENT>
<SENT sid="2" pm="."><plain>Sulphasalazine was discontinued and the patient was given <z:chebi fb="2" ids="2948">azathioprine</z:chebi> for <z:hpo ids='HP_0100279'>ulcerative colitis</z:hpo> and <z:chebi fb="0" ids="27690">acetazolamide</z:chebi> for intracranial <z:hpo ids='HP_0000822'>hypertension</z:hpo> </plain></SENT>
<SENT sid="3" pm="."><plain>Three weeks later, her examination was <z:mpath ids='MPATH_458'>normal</z:mpath> and lumbar puncture revealed an opening pressure of 180-mm <z:chebi fb="0" ids="15377">H(2)O</z:chebi> </plain></SENT>
<SENT sid="4" pm="."><plain>Sulphasalazine is a product of <z:chebi fb="0" ids="20551">5 aminosalicylate</z:chebi> (<z:chebi fb="0" ids="6775">5 ASA</z:chebi>) and there seems to be a relationship between the administration of sulphasalazine and the <z:hpo ids='HP_0003674'>onset</z:hpo> of intracranial <z:hpo ids='HP_0000822'>hypertension</z:hpo> symptoms </plain></SENT>
<SENT sid="5" pm="."><plain>Early diagnosis of intracranial <z:hpo ids='HP_0000822'>hypertension</z:hpo> is important in patients with <z:hpo ids='HP_0100279'>ulcerative colitis</z:hpo> receiving <z:chebi fb="0" ids="6775">5 ASA</z:chebi> treatment to prevent visual complications </plain></SENT>
</text></document>